The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(4-bromophenylthio)quinazoline-2,4-diamine ID: ALA3246662
PubChem CID: 86220238
Max Phase: Preclinical
Molecular Formula: C14H11BrN4S
Molecular Weight: 347.24
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(N)c2cc(Sc3ccc(Br)cc3)ccc2n1
Standard InChI: InChI=1S/C14H11BrN4S/c15-8-1-3-9(4-2-8)20-10-5-6-12-11(7-10)13(16)19-14(17)18-12/h1-7H,(H4,16,17,18,19)
Standard InChI Key: ZVRAALLIIFQTIW-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
16.8432 -17.3756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8432 -18.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5485 -18.5973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5485 -16.9629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2538 -17.3756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2548 -18.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9591 -18.5983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6669 -18.1910 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6659 -17.3738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9571 -16.9639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3735 -16.9650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.9590 -19.4155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1361 -18.6024 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.4278 -18.1949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4255 -17.3787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7180 -16.9712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0140 -17.3809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0184 -18.2023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7218 -18.6061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3045 -16.9754 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 2 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
9 11 1 0
7 12 1 0
2 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 347.24Molecular Weight (Monoisotopic): 345.9888AlogP: 3.71#Rotatable Bonds: 2Polar Surface Area: 77.82Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.91CX LogP: 4.00CX LogD: 3.88Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.74Np Likeness Score: -1.06
References 1. Elslager EF, Hutt MP, Jacob P, Johnson J, Temporelli B, Werbel LM, Worth DF, Rane L.. (1979) Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity., 22 (10): [PMID:117107 ] [10.1021/jm00196a019 ] 2. Elslager EF, Jacob P, Johnson J, Werbel LM, Worth DF, Rane L.. (1978) Folate antagonists. 13. 2,4-Diamino-6-](alpha,alpha,alpha-trifluoro-m-tolyl)thio]quinazoline and related 2,4-diamino-6-[(phenyl- and naphthyl)thio]quinazolines, a unique class of antimetabolites with extraordinary antimalarial and antibacterial effects., 21 (10): [PMID:102792 ] [10.1021/jm00208a010 ]